Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
Dec. 31, 2017
Jun. 30, 2017
Current assets :    
Cash $ 12,322 $ 14,326
Accounts receivable (net of allowance of $0 and $0, respectively) 321 382
Inventory 10,115 95,865
Other current assets 74,968 3,491
Total current assets 97,726 114,064
Total assets 97,726 114,064
Current liabilities:    
Accounts payable 229,897 205,961
Accrued expense-related party 192,000 180,000
Convertible notes payable - net of discount 418,992 151,020
Fair value of derivative liabilities 1,016,453 44,022
Short-term borrowings 2,000 3,096
Advance from shareholders 11,795 995
Total current liabilities 1,871,137 585,094
Commitments and contingencies
Stockholders' deficit:    
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 35,368,758 issued and outstanding as of December 31, 2017 and 29,724,432 outstanding as of June 30, 2017, respectively) 35,369 29,724
Additional paid in capital 3,790,954 2,880,467
Accumulated deficit (5,599,734) (3,381,221)
Total stockholders' deficit (1,773,411) (471,030)
Total Liabilities and Stockholders' Deficit $ 97,726 $ 114,064